Other
J&J Q3 net income drops 7 percent on higher costs
Johnson & Johnson's third-quarter profit fell 7 percent as increased research and production costs offset higher sales for its medicines and medical devices and new revenue from its biggest acquisition ever.
Oct 16, 2012
0
0